Skip to content

Role of Vitamin D in Innate Immunity to Tuberculosis

Vitamin D Supplementations as Adjunct to Anti-tuberculosis Drugs in Mongolia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01244204
Enrollment
120
Registered
2010-11-19
Start date
2009-11-30
Completion date
2011-03-31
Last updated
2012-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis, Vitamin D Deficiency

Keywords

vitamin D deficiency, tuberculin sin test, immunity, tuberculosis

Brief summary

The investigators proposed a pilot study preparatory to developing a randomized trial of vitamin D for the prevention of TB infection. The specific aims are presented below: 1. To recruit subjects, obtain consent, distribute vitamin D supplements to the children in the schools, obtain blood samples and transport them to the United States. 2. To test the hypothesis that daily vitamin D supplementation will increase plasma levels of 25(OH)D, and restore TLR-induced antimicrobial activity in monocytes/macrophages tested in vitro.

Interventions

DIETARY_SUPPLEMENTVitamin D

Daily dose of 800IU of vitamin D

DIETARY_SUPPLEMENTPlacebo

Identically appearing capsules

Sponsors

Harvard School of Public Health (HSPH)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Eligible subjects will be children age 12 to 15 years inclusive in public school, located in Songino-Khairhan district, who are residents of Ulaanbaatar, and whose parents have given informed consent and who accent to participate in the study.

Exclusion criteria

* Individuals with pre-existing calcium, parathyroid conditions, or type I diabetes, sarcoidosis, or who require chronic diuretic therapy including calcium channel blockers, or who are cognitively impaired.

Design outcomes

Primary

MeasureTime frame
Serum vitamin D levels6 months
Tuberculin Skin Test conversion6 monhs

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026